JP Morgan Lifts Molina Health Price Target to $225 From $220
JP Morgan raised its Molina Health price target to $225 from $220 and kept a Neutral rating. Dow Jones Newswires reports, citing Benzinga ratings data.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Dow Jones Newswires reports that JP Morgan increased its price target on Molina Health shares to $225 from $220.
The bank kept its Neutral rating on the stock. The information comes from a ratings roundup published by Benzinga.
why it matters
A single analyst's target change rarely moves the broader market. For Molina investors, it signals a modest rise in the bank's valuation while its cautious stance remains unchanged.
tags
instruments
sources
- Molina Health Price Target Raised to $225.00/Share From $220.00 by JP Morgan — Dow Jones Newswires, 27 October 2026 at 19:40 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗